Nancy Pelosi’s 100 hour march continues today, as the House takes up a bill that will allow the U.S. Government to negotiate directly with pharmaceutical companies when purchasing drugs for the newly-enacted Medicare Part D program. Like raising the minimum wage, this proposal represents Pelosi’s efforts to find low-hanging liberal fruit — in other words, domestic programs that, unlike the bulk of the liberal agenda, poll well.
Raising the minimum wage isn’t a very good idea, but it does not threaten great harm. However, the same cannot be said for using the government’s negotiating power to regulate drug prices.
To understand the issue, I recommend this piece by Pat Cleary at his Shop Floor blog, and this one by Robert Goldberg in the Washington Times.
-
-
Most Read on Power Line
Donate to PL
-
Our Favorites
- American Greatness
- American Mind
- American Story
- American Thinker
- Aspen beat
- Babylon Bee
- Belmont Club
- Churchill Project
- Claremont Institute
- Daily Torch
- Federalist
- Gatestone Institute
- Hollywood in Toto
- Hoover Institution
- Hot Air
- Hugh Hewitt
- InstaPundit
- Jewish World Review
- Law & Liberty
- Legal Insurrection
- Liberty Daily
- Lileks
- Lucianne
- Michael Ramirez Cartoons
- Michelle Malkin
- Pipeline
- RealClearPolitics
- Ricochet
- Steyn Online
- Tim Blair
Media
Subscribe to Power Line by Email
Temporarily disabled
Notice: All comments are subject to moderation. Our comments are intended to be a forum for civil discourse bearing on the subject under discussion. Commenters who stray beyond the bounds of civility or employ what we deem gratuitous vulgarity in a comment — including, but not limited to, “s***,” “f***,” “a*******,” or one of their many variants — will be banned without further notice in the sole discretion of the site moderator.